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Optimal phosphorus management technologies on dairy farms
Phosphorus (P) management is a national
issue with respect to water quality and the sustainability of animal agriculture. A major problem facing dairy farms is the surplus of phosphorus resulting from the excess quantity of
the element in feeds and minerals. The cow can
only utilize a small fraction of the nutrient,
excess phosphorus is excreted in manure. It
accumulates in soils, increasing the potential
for phosphorus losses in runoff, which in turn
contributes to accelerated water quality
deterioration.
The traditional approach to reduce phosphorus problems is focused on the management of manure at the end of the production
cycle, i.e. after manure is excreted. A more efficient and cost-effective approach of managing
phosphorus on dairy farms is to eliminate
excess of it in diets with optimal nutrient balances in the rations. This front-end approach
minimizes phosphorus excretion in manure
without impairing cow performance and farm
profitability. This approach saves feed cost for
the farmer.
In fact, phosphorus is an essential nutrient,
needed by all plants and living species. The
problem is that in many areas soils already have
phosphorus buildup to levels far exceeding
crop needs. Manure added as fertilizer compounds the problem. Run-offs from these highphosphorus soils to rivers, streams, and the
Chesapeake Bay impede the water quality and
interfere with balance of plant and marine life
in the watershed.
To help dairy farmers better manage phosphorus for enhanced farm profitability and
environmental quality, a multi-state, multi-disciplinary project ($1,797,000 for year 20022005) supported by the USDA-IFAFS Program
was recently initiated to develop optimal phosphorus management technologies on dairy
farms. The long-term goal is to develop and
deliver practical, scientifically sound, and economically viable phosphorus source control
measures and management tools that sustain
dairy farming and protect the environment.
Penn is the lead institution with Dr.
Zhengxia Dou as the project director and Dr.
James Ferguson the co-director. Researchers
from five other institutions are collaborating on
the project. They visit farms in their areas and
collect samples, then send farm information
and samples to Penn for processing and analyses. Drs. Dou and Ferguson are in charge of
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project planning, monitoring, implementation,
evaluation, supervising, and reporting findings
to USDA. They are also working with 20 dairy
farms in Southeast Pennsylvania and Delaware
to collect farm information and samples, just
like the collaborators do for this project.
The specific objectives of the project are:
(A) Determine the dietary P range adequate
for optimal cow performance but not in
excess of animal needs by combining farm
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The five states participating in the project make up
much of the Chesapeake Bay watershed.

data across five states (PA, NY, DE, MD,
VA) with research findings.
(B) Develop easy-to-use management tools
including a fecal P testing procedure for

assessing diet P adequacy vs. overfeeding
and a modified ration formulation software program for balancing diet P and
nitrogen.
(C) Establish quantitative relationships
between dairy diets, fecal P, and P loss in
runoff through laboratory and field-scale
experiments.
(D) Provide training and education to veterinarians, nutritionists, producers, nutrient
management personnel.
(E) Prepare a “white paper” on best management practices for P in dairy operations
and present it to state/regional nutrient
management commissions.
The results of the study will be disseminated rapidly through existing multiple outreach
channels. Project findings will be equally applicable on small, medium, or large farms. Project
impact will be large-scale and long-lasting
beyond the project period.
The principal investigators are Dr. Zhengzia
Dou and Dr. James D. Ferguson at the School.
The collaborating scientists are: Dr. L.E. Chase,
Cornell University, Dr. K.F. Knowlton, Virginia
Polytechnic Institute, Dr. R.A. Kohn, University
of Maryland, Dr. J.T. Sims, University of
Delaware, Dr. Z. Wu, Penn State University.

Clinic to bench
Christopher Hunter’s lab on the second
floor of Rosenthal is overflowing with equipment and people. In the broadest sense, the
work here focuses on the role of cytokines in
triggering immune responses. Cytokines, soluble messenger proteins, tell cells when to
mount an immune response or when to stop
such response. Cytokines are indispensable for
the ability to fight diseases.
A major aspect of the basic research work
here involves Toxoplasma gondii, a protozoan
parasite that infects most warmblooded animals, including birds and man. Cats, domestic
and wild, are the only known definitive host of
the organism and serve as the main reservoir.
Toxoplasmosis occurs world-wide. It is a major
concern for pregnant women because the disease causes birth defects in fetuses. The disease
is also a major concern for people with
immune system dysfunction; here it causes
meningoencephalitis.
Hunter’s laboratory is home not only to
bench scientists but also to clinicians who are

pursuing basic research to enhance their clinical
work. Dr. Lillian Aronson,V’92, assistant professor of surgery and head of the feline kidney
transplant program at VHUP, and Dr. Nicola
Mason, on leave from the section of medicine,
and in the process of earning a Ph.D., are both
working with Dr. Hunter’s group to learn more
about the immune complex.
Dr. Aronson came to the lab to evaluate the
effects of a drug CTLA4-Ig on feline lymphocyte function. The theory behind this drug is
that it is more specific in its mechanism of
action, i.e. it can hopefully still prevent rejection
(suppress T lymphocytes that are specifically
involved with rejection), but also allow a patient
to fight off an infection (not have an affect on
memory T cells).
Some of her patients, after a kidney transplant when they received regular doses of
cyclosporine and prednisolone as immunosuppressants to prevent rejection of the new kidney, suddenly developed acute generalized toxoplasmosis (because of a reactivation of a latent

